<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2101244770
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DROLINA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FUROSEMIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        30.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ALPHA PHARMA INDUSTRY " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ALPHA PHARMA INDUSTRY 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2732]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Alpha Pharma Industry
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ALPHA PHARMA INDUSTRY
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C03CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>DROLINA </strong>contains furosemide which is a diuretic that promotes urine production.</p><p><strong>DROLINA </strong>tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome.<strong> DROLINA</strong> is particularly useful when an agent with greater diuretic potential is desired.</p><p>Oral <strong>DROLINA </strong>may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with <strong>DROLINA </strong>alone.<strong> </strong></p><p><strong>How DROLINA tablets work</strong></p><p><strong>DROLINA</strong> tablets work by helping you to pass more water (urine) than you usually do. If the extra water in your body is not removed, it can put extra strain on the heart, blood vessels, lungs, kidneys or liver.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take </strong><strong>DROLINA </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are <strong>allergic</strong> (hypersensitive) to furosemide, other sulfonamide related drugs or any of the other ingredients in furosemide tablets (see section 6)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>severe kidney damage</strong> which has stopped them working properly and producing urine</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have very <strong>low levels of potassium, sodium or other electrolytes</strong> in your blood or low blood volume (your doctor will be able to advise you)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are <strong>dehydrated</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>low blood pressure</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you take <strong>potassium supplements</strong> or <strong>potassium sparing diuretics</strong> for high blood pressure (e.g. amiloride or spironolactone)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>liver cirrhosis</strong> (tiredness, weakness, water retention, feeling or being sick, loss of weight or appetite, yellowing skin or eyes, itch) or <strong>liver encephalopathy</strong> (confusion, altered levels of consciousness and coma as a result of liver failure)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>Addison&rsquo;s disease</strong> (low levels of corticosteroid hormones secreted)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>digitalis poisoning</strong> (feeling or being sick, high levels of potassium in the blood, slow, fast or irregular heartbeats).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are <strong>breast-feeding</strong></p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking <strong>DROLINA if:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; your blood pressure is very low.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are taking digoxin, used to treat heart problems</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you suffer from acute porphyria symptoms of which may include severe stomach, back or thigh pain. Nausea, vomiting or constipation may also present along with weakness in arms and legs.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are going to give this medicine to a baby that was born too early</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are taking any other water tablets</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are elderly, if you are on other medications that can cause a drop in blood pressure, and if you have other medical conditions that are risks for a drop in blood pressure.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have already existing (established) or underlying (latent) diabetes mellitus; regular monitoring of blood sugar levels is required.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have gout; regular monitoring of blood uric acid levels is required.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have difficulty passing urine (e.g. due to enlarged prostate, obstruction of the kidney, or shrinking of the tube that runs from the kidney to the bladder).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; your blood protein level is decreased, e.g. in nephrotic syndrome (which is characterized by protein loss, lipid metabolism disorders and water accumulation); dosage must be carefully adjusted.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have rapidly progressive kidney dysfunction in connection with a serious liver disease such as liver cirrhosis (hepatic renal syndrome).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have blood flow disorders in the brain vessels or heart vessels, since you would be particularly at risk if you experienced a sharp adverse drop in blood pressure.</p><p><strong>Your doctor will want to monitor you, and may take blood for testing while you are taking this medicine.</strong></p><p><strong>Children and adolescents </strong></p><p>In<strong> </strong>premature infants <strong>DROLINA</strong> may precipitate nephrocalcinosis/nephrolithiasis.</p><p>Nephrocalcinosis/nephrolithiasis has also been observed in children under 4 years of age with no history of prematurity who have been treated chronically with <strong>DROLINA</strong>. Monitor renal function, and renal ultrasonography should be considered, in pediatric patients receiving <strong>DROLINA</strong>.</p><p>If <strong>DROLINA</strong> is administered to premature infants during the first weeks of life, it may increase the risk of persistence of patent ductus arteriosus.</p><p><strong>Other medicines and </strong><strong>DROLINA </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. Especially:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines to lower blood pressure, such as ACE inhibitors, renin inhibitors, alpha blockers, calcium channel blockers, diuretics, phenothiazines</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines to treat mental illness (e.g. pimozide, amisulpride, sertindole)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for arrhythmias (e.g. sotalol, amiodarone, flecanide)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; digoxin for your heart</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; moxisylte for Raynaud&rsquo;s syndrome</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nitrates (for angina)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lithium for depression or mania</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sucralfate for stomach ulcers</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; colestyramine or colestipol for high cholesterol</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; non-steroidal anti-inflammatory drugs (NSAIDs) e.g. ibuprofen or naproxen</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; aspirin for pain</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antibiotics for infections that affect your kidneys or ears (e.g. cefaclor, colistin, gentamicin, vancomycin)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; amphoterecin (to treat fungal infections)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chloral hydrate (to treat insomnia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antidepressants (e.g. monoamine oxidase inhibitors (MAOIs))</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines to control diabetes such as insulin or tablets</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antiepileptics e.g. phenytoin or carbamazepine</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; corticosteroids or antihistamines (to treat allergic reactions)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; drugs for ADHD</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; drugs treating cancer e.g. aldesleukin</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; levodopa (for Parkinson&rsquo;s disease)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; oral contraceptives</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; alprostadil for erectile dysfunction</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; certain treatments for asthma such as theophylline or salbutamol</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; probenecid to prevent gout</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; laxatives used over a long period of time</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines or foods containing liquorice</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are about to undergo a procedure where curariform muscle relaxants (e.g. vercuronium) or anesthetics may be used, tell your anesthetist/dentist or healthcare professional If your doctor thinks that you are at increased risk of developing stomach or bowel ulcers, he may also use a preventative ulcer treatment.</p><p><strong>DROLINA </strong><strong>with food and drink</strong></p><p>Eating large quantities of licorice under treatment with <strong>DROLINA</strong> may increase potassium loss.</p><p>You should avoid drinking alcohol while taking <strong>DROLINA</strong> tablets as this may lower your blood pressure further.</p><p><strong>Pregnancy, and breastfeeding </strong></p><p>Do not use <strong>DROLINA</strong> during pregnancy unless your doctor considers it necessary, since the active substance furosemide passes into the placenta.</p><p>Furosemide passes into breast milk and reduces the amount of milk produced. Consequently, you should not be treated with <strong>DROLINA</strong> if you are breast-feeding. <strong>If necessary</strong>, you must stop breast-feeding.</p><p><strong>Driving and using machines </strong></p><p>Do not drive or operate machinery if you feel less alert after taking furosemide tablets.</p><p><strong>DROLINA contains lactose</strong></p><p>Your medicine contains lactose; do not take furosemide tablets if you have been told by your doctor that you have an intolerance to a sugar called lactose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&sect;&nbsp; <strong>Edema</strong></p><p>Therapy should be individualized according to patient response to gain maximal therapeutic response and to determine the minimal dose needed to maintain that response.</p><p>&sect;&nbsp; <em><u>Adults </u></em></p><p>The usual initial dose of <strong>DROLINA</strong> is 20mg to 80mg given as a single dose. Ordinarily a prompt diuresis ensues. If needed, the same dose can be administered 6 to 8 hours later or the dose may be increased. The dose may be raised by 20mg or 40mg and given not sooner than 6 to 8 hours after the previous dose until the desired diuretic effect has been obtained.</p><p>The individually determined single dose should then be given once or twice daily (e.g., at 8 am and 2 pm). The dose of <strong>DROLINA</strong> may be carefully titrated up to 600 mg/day in patients with clinically severe edematous states.</p><p>Edema may be most efficiently and safely mobilized by giving <strong>DROLINA</strong> on 2 to 4 consecutive days each week. When doses exceeding 80 mg/day are given for prolonged periods, careful clinical observation and laboratory monitoring are particularly advisable.</p><p>&sect;&nbsp; <em><u>Children and adolescents</u></em></p><p>The usual initial dose of oral <strong>DROLINA</strong> in pediatric patients is 2 mg/kg body weight, given as a single dose. If the diuretic response is not satisfactory after the initial dose, dosage may be increased by 1 or 2 mg/kg no sooner than 6 to 8 hours after the previous dose. Doses greater than 6 mg/kg body weight are not recommended. For maintenance therapy in pediatric patients, the dose should be adjusted to the minimum effective level.</p><p>&sect;&nbsp; <strong>Hypertension</strong></p><p>Therapy should be individualized according to the patient&rsquo;s response to gain maximal therapeutic response and to determine the minimal dose needed to maintain the therapeutic response.</p><p>&sect;&nbsp; <em><u>Adults </u></em></p><p>The usual initial dose of <strong>DROLINA</strong> for hypertension is 80mg, usually divided into</p><p>40mg twice a day. Dosage should then be adjusted according to response. If response is not satisfactory, other antihypertensive agents can be added.</p><p>Changes in blood pressure must be carefully monitored when <strong>DROLINA</strong> is used with other antihypertensive drugs, especially during initial therapy. To prevent excessive drop in blood pressure, the dosage of other agents should be reduced by at least 50% when <strong>DROLINA</strong> is added to the regimen. As the blood pressure falls under the potentiating effect of <strong>DROLINA</strong>, a further reduction in dosage or even discontinuation of other antihypertensive drugs may be necessary.</p><p><strong>If you take more DROLINA than you should</strong></p><p>If you take more medicine than your doctor has told you to, contact a doctor or your nearest hospital casualty department immediately and take your <strong>DROLINA</strong> tablets with you. &nbsp;Symptoms of an overdose include dehydration and changes in the levels of certain chemicals in the blood.</p><p><strong>If you forget to take </strong><strong>DROLINA </strong></p><p>If you forget to take a dose, take another as soon as you remember. Then take your next dose at the normal time. Do not take double the amount to make up for a forgotten dose.</p><p><strong>If you stop taking </strong><strong>DROLINA </strong></p><p>Speak to your doctor before you stop taking <strong>DROLINA</strong> tablets</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. These effects are normally mild to moderate in nature.</p><p><strong>If you have any of the following side effects while taking your medicine tell your doctor immediately or go to hospital straight away:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe allergic reaction which may include a skin rash, itching, dermatitis, peeling skin, sensitivity to sunlight or sun lamps or fever, swelling of the face, lips, tongue or throat, or difficulty breathing or swallowing</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blistering or peeling of the skin around the lips, eyes, mouth, nose and genitals, flu-like symptoms and fever could be a condition called Stevens-Johnson syndrome.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of blood vessels (vasculitis, which may cause rash, fever and joint or muscle pains) or kidney inflammation, this may change the number of times you pass urine or you may see blood in your urine. You may have a fever, feel drowsy, or notice swelling e.g. of the ankles.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood clot (causing pain, swelling or tenderness in the legs).</p><p><strong>Tell your doctor or pharmacist if you notice any of the following side effects:</strong></p><p><strong>Very common </strong>(may affect more than or equal to 1 in 10 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dehydration, altered balance of fluid or chemicals in the body (e.g. sodium, potassium, chlorine, calcium and magnesium) causing a dry mouth, weakness, tiredness or drowsiness, restlessness, fits, muscle pain, fatigue or cramps, low blood pressure causing loss of concentration and slowed reactions, difficulty passing water, fast or irregular heart rate and feeling and being sick.</p><p><strong>Common </strong>(may affect more than or equal to 1 in 100 and less than 1 in 10 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low blood volume (hypovolaemia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased creatinine and blood urea (seen in blood tests)</p><p><strong>Uncommon </strong>(may affect more than or equal to 1 in 1000 and less than 1 in 100 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anemia causing tiredness, breathlessness, unusual bleeding or bruising</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the body seen in tests such as levels of cholesterol, glucose, uric acid</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gout</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in vision including blurred or yellow vision</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Light-headedness, sensations of pressure in the head, headache, drowsiness, weakness, changes in vision, dry mouth, dizziness when standing.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Irregular heartbeat</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle cramps or weakness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the amount or need to urinate</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tiredness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry mouth, thirst, feeling or being sick, changes in bowel movements including diarrhea and constipation</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deafness (sometimes irreversible)</p><p><strong>Rare </strong>(may affect more or equal to 1 in 10,000 and less than 1 in 1,000 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in blood cells such as amount of white blood cells, reduction of platelets causing a rash fever, sweating, tiredness, and weight loss. Your doctor will perform regular blood tests to ensure no changes have occurred.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Psychiatric disorder NOC causing delusions, hallucinations, disorganized speech</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling &lsquo;pins and needles&rsquo; or tingling sensation</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Confusion, headache, tiredness, generally feeling unwell, fever</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lsquo;Ringing&rsquo; in the ears, loss of hearing usually reversible</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Symptoms of shock such as changes in heart rate, breathlessness, cool clammy skin</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the pancreas causing pains in your abdomen or back and nausea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the liver causing yellowing of the skin or whites of the eyes</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rashes</p><p><strong>Very rare </strong>(may affect less than 1 in 10,000 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Involuntary movements of the muscle</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation or failure of the kidney which may cause back pain or changes in the amount or need to urinate</p><p><strong>Frequency not known (</strong>cannot be estimated from the available data)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Worsening of conditions where there is already balances of fluid or<strong> </strong>chemicals in the body</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute generalized exanthematous pustulosis (AGEP) (acute febrile drug eruption)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness, fainting and loss of consciousness (caused by symptomatic hypotension)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decreased levels of potassium in the body kidney failure after a severe bleeding increased pressure within muscles of the legs or arms after a bleeding, which leads to pain, swelling, altered sensation, numbness or paralysis (compartment syndrome after a bleeding)</p><p>Ask your doctor or pharmacist for further information about the side effects.</p><p><strong>To report any side effect(s): </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Saudi Arabia:</em></strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:378px"><tbody><tr><td style="vertical-align:top"><p>&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p></td></tr></tbody></table><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Other GCC States:</em></strong></p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the carton and blister after &lsquo;EXP&rsquo;. The expiry date refers to the last day of that month.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine in the original pack to protect from light, in a dry place.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine if you notice that the pack is changed or showing signs of tampering.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The <strong>active</strong> substance is furosemide.</p><p>&sect;&nbsp; <strong><em>DROLINA </em></strong><em>20mg Tablets</em></p><p>▪&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each tablet contains 20 mg of furosemide.</p><p>&sect;&nbsp; <strong><em>DROLINA </em></strong><em>40mg Tablets</em></p><p>▪&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each tablet contains 40 mg of furosemide.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The <strong>other</strong> ingredients are: lactose monohydrate, croscarmellose sodium, starch, colloidal silicone dioxide, magnesium stearate, and purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                DROLINA 20 mg tablets are white to off-white, round, flat face bevel edge tablets debossed JS55 on one side and plain on other side.
DROLINA 40 mg tablets are white to off-white, round, flat face, bevel edge tablets debossed JS49 on one side and Score line on other side.
DROLINA 20 mg tablets and DROLINA 40 mg tablets are available in pack containing 100 tablets. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Alpha Pharma,</p><p>King Abdullah Economic city, Kingdom of Saudi Arabia</p><p>Tel:&nbsp;+966 12 21 29013</p><p>Email: regulatory@alphapharma.com.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                9/2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي <strong>درولينا</strong> على فوروسيميد وهو مدر للبول يعزز إنتاج البول.</p><p dir="RTL">تستخدم أقراص <strong>درولينا</strong> للبالغين والأطفال لعلاج الوذمة المرتبطة بفشل القلب الاحتقاني وتليف الكبد وأمراض الكلى، بما في ذلك المتلازمة الكلوية. <strong>درولينا</strong> مفيد بشكل خاص عند الرغبة في استخدام دواء ذو قدرة أكبر على إدرار البول.</p><p dir="RTL">يمكن استخدام <strong>درولينا</strong> عن طريق الفم في البالغين لعلاج ارتفاع ضغط الدم وحده أو مع أدوية أخرى خافضة للضغط. مرضى ارتفاع ضغط الدم الذين لا يمكن السيطرة عليهم بشكل كاف بأدوية مدرات البول ربما لن يتم السيطرة عليهم بشكل كاف باستخدام <strong>درولينا</strong> وحده.</p><p dir="RTL"><strong>كيف تعمل أقراص درولينا</strong></p><p dir="RTL">تساعد أقراص <strong>درولينا</strong> على إدرار المزيد من الماء (التبول) أكثر مما تفعل عادة. إذا لم تتم إزالة الماء الزائد من جسمك، فقد يؤدي ذلك إلى زيادة الضغط على القلب أو الأوعية الدموية أو الرئتين أو الكلى أو الكبد.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول درولينا</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من <strong>حساسية</strong> (شديدة الحساسية) تجاه فوروسيميد، أو أدوية أخرى مرتبطة بالسلفوناميد أو أي من المكونات الأخرى في أقراص فوروسيميد (انظر القسم 6)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك <strong>تلف شديد في الكلى</strong> أدى إلى توقفهم عن العمل بشكل صحيح وإخراج البول</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك <strong>مستويات منخفضة جدًا من البوتاسيوم أو الصوديوم أو أملاح أخرى</strong> في دمك أو انخفاض حجم الدم (سيكون طبيبك قادرًا على تقديم النصح لك)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من <strong>الجفاف</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك <strong>ضغط دم منخفض</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول <strong>مكملات البوتاسيوم </strong>أو<strong> مدرات البول التي تحافظ على البوتاسيوم</strong> لارتفاع ضغط الدم (مثل أميلوريد أو سبيرونولاكتون)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من <strong>تليف الكبد</strong> (التعب، والضعف، واحتباس الماء، والشعور أو المرض، وفقدان الوزن أو الشهية، واصفرار الجلد أو العينين، والحكة) أو اعتلال دماغي الكبد (الارتباك، وتغير مستويات الوعي والغيبوبة نتيجة لفشل الكبد)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا <strong>بمرض أديسون</strong> (مستويات منخفضة من هرمونات الكورتيكوستيرويد التي تفرز)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من <strong>تسمم الديجيتال</strong> (الشعور أو المرض، مستويات عالية من البوتاسيوم في الدم، ضربات قلب بطيئة أو سريعة أو غير منتظمة).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت <strong>مرضعة</strong></p><p dir="RTL"><strong>الاحتياطات والتحذيرات</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل تناول <strong>درولينا</strong> إذا:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك انخفاض حاد في ضغط الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول الديجوكسين ، الذي يستخدم لعلاج مشاكل القلب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من أعراض البرفيريّة الحادة والتي قد تشمل آلام شديدة في البطن أو الظهر أو الفخذ. قد يحدث أيضًا الغثيان والقيء أو الإمساك مع ضعف في الذراعين والساقين.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت ستعطي هذا الدواء لطفل ولد مبكرًا جدًا</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول أي أدوية أخرى مدرة للبول</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت مسناً، إذا كنت تتناول أدوية أخرى يمكن أن تسبب انخفاضاً في ضغط الدم، وإذا كنت تعاني من حالات طبية أخرى قد تؤدي إلى انخفاض ضغط الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك بالفعل داء السكري (مثبت) أو داء السكري الكامن (الكامن)؛ فسيتطلب متابعة منتظمة لمستويات السكر في الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك النقرس؛ فسيتطلب متابعة منتظمة لمستويات حمض اليوريك في الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك صعوبة في التبول (على سبيل المثال بسبب تضخم البروستاتا أو انسداد الكلى أو تقلص الأنبوب الذي يمتد من الكلى إلى المثانة).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك انخفاض في مستوى البروتين في الدم، على سبيل المثال في المتلازمة الكلوية (التي تتميز بفقدان البروتين واضطرابات التمثيل الغذائي للدهون وتراكم الماء)؛ يجب تعديل الجرعة بعناية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك خلل في وظائف الكلى سريع التفاقم بسبب مرض كبدي خطير مثل تليف الكبد (المتلازمة الكلوية الكبدية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من اضطرابات في تدفق الدم في أوعية الدماغ أو الأوعية القلبية، حيث ستكون معرضًا للخطر بشكل خاص إذا كنت تعاني من انخفاض حاد في ضغط الدم.</p><p dir="RTL"><strong>قد يقوم طبيبك بمتابعة حالتك، وقد يقوم بإجراء فحوصات للدم أثناء تناولك هذا الدواء.</strong></p><p dir="RTL"><strong>الأطفال والمراهقون</strong></p><p dir="RTL">قد يؤدي <strong>درولينا</strong> عند الرضع الخدج إلى حدوث تكلس كلوي أو تحص كلوي.</p><p dir="RTL">كما لوحظ التكلس كلوي أو التحص الكلوي في الأطفال أقل من 4 سنوات دون تاريخ من الخداج الذين تم علاجهم بشكل مزمن مع <strong>درولينا</strong>. يجب متابعة وظائف الكلى، والموجات فوق الصوتية الكلوية، في مرضى الأطفال الذين يتلقون <strong>درولينا</strong>.</p><p dir="RTL">إذا تم إعطاء <strong>درولينا</strong> للرضع الخدج خلال الأسابيع الأولى من الحياة، فقد يزيد من خطر استمرار القناة الشريانية السالكة.</p><p dir="RTL"><strong>تناول أدوية أخرى مع درولينا</strong></p><p dir="RTL">يرجى استشارة الطبيب أو الصيدلي إذا كنت تستخدم أو استخدمت مؤخرًا أو من المتوقع أن تستخدم أي أدوية أخرى بما فيها تلك الأدوية التي يمكن الحصول عليها بدون وصفة طبية. وتحديدًا:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الخافضة لضغط الدم، مثل مثبطات الإنزيم المحول للأنجيوتنسين ومثبطات الرينين ومثبطات ألفا ومثبطات قنوات الكالسيوم ومدرات البول والفينوثيازين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية علاج الأمراض العقلية (مثل بيموزيد ، أميسولبرايد ، سرتيندول)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية عدم انتظام ضربات القلب (مثل سوتالول ، أميودارون ، فليكانيد)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الديجوكسين لقلبك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موكسيسايليت لمتلازمة رينود</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النترات (للذبحة الصدرية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الليثيوم للاكتئاب أو الهوس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوكرالفات لقرحة المعدة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كوليستيرامين أو كوليستيبول لارتفاع الكوليسترول</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العقاقير غير الستيرويدية المضادة للالتهابات (مضادات الالتهاب غير الستيروئيدية) على سبيل المثال ايبوبروفين أو نابروكسين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأسبرين للألم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المضادات الحيوية للعدوى التي تؤثر على الكلى أو الأذنين (مثل سيفاكلور ، كوليستين ، جنتاميسين ، فانكومايسين)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأمفوتريسين (لعلاج الالتهابات الفطرية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هيدرات الكلورال (لعلاج الأرق)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الاكتئاب (مثل مثبطات أوكسيديز أحادية الأمين)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية للسيطرة على داء السكري مثل الأنسولين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الصرع مثل الفينيتوين أو كاربامازيبين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكورتيكوستيرويدات أو مضادات الهيستامين (لعلاج تفاعلات الحساسية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية اضطراب فرط الحركة ونقص الانتباه</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تعالج السرطان مثل الديسلوكين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ليفودوبا (لمرض باركنسون)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موانع الحمل الفموية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألبروستاديل لعلاج ضعف الانتصاب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاجات معينة للربو مثل الثيوفيلين أو السالبوتامول</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البروبينسيد لمنع النقرس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الملينات التي تستخدم لفترة طويلة من الزمن</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية أو الأطعمة التي تحتوي على عرق السوس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت على وشك الخضوع لعملية تتطلب استخدام مرخيات العضلات (مثل الفركورونيوم) أو أدوية مخدرة، فأخبر طبيب التخدير/ طبيب الأسنان أو الممارس الصحي إذا كان طبيبك يعتقد أنك معرض لخطر الإصابة بقرحة المعدة أو الأمعاء، فقد يستخدم أيضًا علاجًا وقائيًا للقرحة.</p><p dir="RTL"><strong>تناول درولينا مع الأطعمة والمشروبات</strong></p><p dir="RTL">قد يؤدي تناول كميات كبيرة من عرق السوس تحت العلاج مع <strong>درولينا </strong>إلى زيادة فقد البوتاسيوم.</p><p dir="RTL">يجب تجنب شرب الكحول أثناء تناول أقراص <strong>درولينا </strong>لأن ذلك قد يؤدي إلى خفض ضغط الدم بشكل أكبر.</p><p dir="RTL"><strong>الحمل والإرضاع</strong></p><p dir="RTL">لا تستخدم <strong>درولينا </strong>أثناء الحمل إلا إذا رأى طبيبك ذلك ضروريًا، لأن المادة الفعالة فوروسيميد تمر عبر المشيمة.</p><p dir="RTL">يمر فوروسيميد في حليب الثدي ويقلل من كمية الحليب المنتجة. وبالتالي، لا ينبغي أن تعالج <strong>ب</strong><strong>د</strong><strong>رولينا </strong>إذا كنت مرضعة. إذا لزم الأمر، يجب عليك التوقف عن الإرضاع.</p><p dir="RTL"><strong>قيادة المركبات و تشغيل الآلات</strong></p><p dir="RTL">ينصح بعدم قيادة المركبات أو تشغيل الآلات عند الشعور بقلة الانتباه بعد تناول أقراص فوروسيميد.</p><p dir="RTL"><strong>يحتوي درولينا على اللاكتوز</strong></p><p dir="RTL">يحتوي دوائك على اللاكتوز. لا تأخذ أقراص فوروسيميد إذا أخبرك طبيبك أن لديك حساسية تجاه سكر يسمى اللاكتوز.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احرص دائمًا على تناول هذا الدواء تمامًا كما أخبرك طبيبك. استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p dir="RTL"><strong>&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>وذمة</strong></p><p dir="RTL">يجب أن يكون العلاج فرديًا وفقًا لاستجابة المريض للحصول على أقصى استجابة علاجية ولتحديد الحد الأدنى من الجرعة اللازمة للحفاظ على هذه الاستجابة.</p><p dir="RTL"><em>&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em><u>البالغين</u></em></p><p dir="RTL">الجرعة الأولية المعتادة من <strong>درولينا </strong>هي 20 ملجم إلى 80 ملجم تعطى كجرعة فردية. عادة ما يترتب على ذلك إدرار فوري للبول. إذا لزم الأمر، يمكن إعطاء نفس الجرعة بعد 6 إلى 8 ساعات أو من الممكن زيادتها. يمكن زيادة الجرعة بمقدار 20 ملجم أو 40 ملجم ولا يتم تناولها قبل 6 إلى 8 ساعات من الجرعة السابقة حتى يتم الحصول على مغعول إدرار البول المطلوب.</p><p dir="RTL">يجب بعد ذلك إعطاء الجرعة الفردية المحددة مرة أو مرتين يوميًا (على سبيل المثال، الساعة 8 صباحًا و 2 مساءً). يمكن زيادة جرعة <strong>درولينا </strong>بعناية حتى 600 ملجم في اليوم في المرضى الذين يعانون من حالات وذمة شديدة سريريًا.</p><p dir="RTL">من الممكن السيطرة على الوذمة بشكل فعال وآمن عند تناول <strong>درولينا </strong>خلال 2 إلى 4 أيام متتالية كل أسبوع. عند تناول جرعات تتجاوز 80 ملجم في اليوم لفترات طويلة، فينصح بمتابعة الحالة السريرية والمختبرية للمريض.</p><p dir="RTL"><em>&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em><u>الأطفال والمراهقون</u></em></p><p dir="RTL">الجرعة الأولية المعتادة من <strong>درولينا </strong>في الأطفال عن طريق الفم هي 2 ملجم لكل كجم من وزن الجسم، تعطى كجرعة فردية. إذا كانت نتيجة إدارا البول بعد الجرعة الأولية غير مرضية، فمن الممكن زيادة الجرعة بمقدار 1 أو 2 ملجم لكل كجم بعد الجرعة السابقة بـ 6 إلى 8 ساعات. لا ينصح بجرعات أكبر من 6 ملجم لكل كجم من وزن الجسم. يتم تعديل الجرعة للحد الأدنى من فعالية الدواء كجرعة داعمة.</p><p dir="RTL"><strong>&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ارتفاع ضغط الدم</strong></p><p dir="RTL">يجب أن يكون العلاج فرديًا وفقًا لاستجابة المريض للحصول على أقصى استجابة علاجية ولتحديد الحد الأدنى من الجرعة اللازمة للحفاظ على الاستجابة العلاجية.</p><p dir="RTL"><em>&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em><u>البالغين</u></em></p><p dir="RTL">الجرعة الأولية المعتادة من <strong>درولينا </strong>لارتفاع ضغط الدم هي 80 ملجم، وعادة ما تنقسم إلى 40 ملجم مرتين في اليوم. يجب بعد ذلك تعديل الجرعة وفقًا للاستجابة. إذا كانت الاستجابة غير مرضية، يمكن إضافة أدوية أخرى خافضة للضغط.</p><p dir="RTL">يجب متابعة التغيرات في ضغط الدم بعناية عند استخدام <strong>درولينا </strong>مع الأدوية الأخرى الخافضة للضغط، وخاصة أثناء العلاج الأولي. لمنع الانخفاض الحاد في ضغط الدم، يجب تقليل جرعة الأدوية الأخرى بنسبة 50 ٪ على الأقل عند إضافة <strong>درولينا </strong>إلى الخطة العلاجية. نظرًا لتأثير <strong>درولينا </strong>في خفض ضغط الدم، فقد يكون من الضروري تعديل جرعة الأدوية الأخرى الخافضة لضغط الدم أو حتى إيقافها.</p><p dir="RTL"><strong>إذا تناولت درولينا أكثر مما ينبغي</strong></p><p dir="RTL">إذا تناولت الدواء أكثر مما أخبرك به طبيبك، فاتصل بالطبيب أو توجه لأقرب مستشفى على الفور وخذ أقراص <strong>درولينا</strong> معك. تشمل أعراض الجرعة الزائدة تشمل الجفاف والتغيرات في مستويات بعض المواد الكيميائية في الدم.</p><p dir="RTL"><strong>إذا نسيت تناول درولينا</strong></p><p dir="RTL">إذا نسيت تناول الجرعة، فتناول جرعة أخرى بمجرد أن تتذكرها. ثم تناول جرعتك التالية في الوقت العادي. لا تأخذ ضعف الكمية لتعويض الجرعة المنسية.</p><p dir="RTL"><strong>إذا توقفت عن تناول درولينا</strong></p><p dir="RTL">تحدث إلى طبيبك قبل التوقف عن تناول أقراص <strong>درولينا.</strong></p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كغيره من الأدوية يمكن أن يسبب بعض الأعراض الجانبية مع أنها لا تحدث لدى جميع الأشخاص. عادة ماتكون هذه الأعراض خفيفة إلى متوسطة بطبيعتها.</p><p dir="RTL"><strong>إذا كان لديك أي من الأعراض الجانبية التالية أثناء تناول الدواء، أخبر طبيبك أو اذهب إلى المستشفى على الفور:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رد فعل تحسسي شديد قد يشمل طفح جلدي، حكة، التهاب الجلد، تقشير الجلد، حساسية لأشعة الشمس أو الأشعة فوق البنفسجية أو الحمى، تورم الوجه، الشفتين، اللسان أو الحلق، أو صعوبة التنفس أو البلع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور تقرحات أو تقشر في الجلد حول الشفتين والعينين والفم والأنف والأعضاء التناسلية وأعراض تشبه أعراض الأنفلونزا والحمى يمكن أن تكون حالة تسمى متلازمة ستيفنز جونسون.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية (التهاب الأوعية الدموية، الذي قد يسبب طفح جلدي وحمى وآلام في المفاصل أو العضلات) أو التهاب الكلى، وهذا قد يغير عدد مرات التبول أو قد يصاحب البول دم. قد تصاب بالحمى، أو تشعر بالنعاس، أو تلاحظ تورمًا، على سبيل المثال في الكاحلين.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جلطة دموية (تسبب ألمًا أو تورمًا أو إيلامًا في الساقين).</p><p dir="RTL"><strong>أخبر طبيبك أو الصيدلي إذا لاحظت أيًا من الآثار الجانبية التالية:</strong></p><p dir="RTL"><strong>شائع جدًا </strong>(قد يؤثر على أكثر من أو يساوي 1 من 10 أشخاص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجفاف ، وتغيير توازن السوائل أو المواد الكيميائية في الجسم (مثل الصوديوم والبوتاسيوم والكلور والكالسيوم والمغنيسيوم) مما يؤدي إلى جفاف الفم والضعف والتعب أو النعاس والأرق والنوبات وآلام العضلات والتعب أو التشنجات وانخفاض ضغط الدم مما يسبب فقدان التركيز وردود الفعل البطيئة ، وصعوبة التبول ، وسرعة أو عدم انتظام ضربات القلب والشعور والمرض.</p><p dir="RTL"><strong>شائعة </strong>(يؤثر على أكثر من أو يساوي 1 من 100 إلى أقل من 1 من 10 أشخاص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض حجم الدم (نقص حجم الدم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الكرياتينين واليوريا في الدم (يتم ملاحظتها في فحوصات الدم)</p><p dir="RTL"><strong>غير شائعة </strong>(يؤثر على أكثر من أو يساوي 1 من 1,000 إلى أقل من 1 من 100 أشخاص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقر الدم يسبب التعب وضيق التنفس والنزيف أو الكدمات غير العادية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيرات في الجسم التي تظهر في الاختبارات مثل مستويات الكوليسترول والسكر وحمض البوليك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النقرس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في الرؤية بما في ذلك عدم وضوح الرؤية أو اصفرارها</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوخة، إحساس بالضغط في الرأس، صداع، نعاس، ضعف، تغيرات في الرؤية، جفاف الفم، دوار عند الوقوف.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب نبضات القلب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقلصات العضلات أو ضعفها</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في كمية التبول أو الحاجة إليه</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التعب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم، والعطش، والشعور بالمرض، وتغيرات في حركة الأمعاء بما في ذلك الإسهال والإمساك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصمم (لا رجعة فيه في بعض الأحيان)</p><p dir="RTL"><strong>نادرة </strong>(يؤثر على أكثر من أو يساوي 1 من 10,000 إلى أقل من 1 من 1,000 أشخاص)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في خلايا الدم مثل كمية خلايا الدم البيضاء، وانخفاض عدد الصفائح الدموية مما يؤدي إلى طفح جلدي وحمى، والتعرق، والتعب، وفقدان الوزن. سيقوم طبيبك بإجراء فحوصات دم منتظمة للتأكد من عدم حدوث تغييرات.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب نفسي يسبب أوهام وهلوسة وحديث غير متزن</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور &rsquo;بوخز&lsquo; أو الإحساس بالوخز</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتباك، صداع، تعب، شعور عام بالتوعك، حمى</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rsquo;طنين&lsquo; في الأذنين ، وفقدان السمع عادة ما يصبح صمم دائم</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض الصدمة مثل التغيرات في معدل ضربات القلب، وضيق التنفس، وبرودة الجلد الرطب</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس يسبب آلام في البطن أو الظهر والغثيان</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في الكبد تسبب اصفرار الجلد أو بياض العينين</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي</p><p dir="RTL"><strong>نادرة جدًا </strong>(يؤثر على أقل من 1 من 10,000 أشخاص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحركات اللاإرادية للعضلة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب أو فشل الكلى الذي قد يسبب آلام الظهر أو تغيرات في الكمية أو الحاجة للتبول</p><p dir="RTL"><strong>غير معروف </strong>(لا يمكن تقديره من البيانات المتاحة)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تدهور الحالة حيث يكون هناك توازن بالسوائل أو المواد الكيميائية في الجسم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البثور الطفيلي الحاد المعمم (AGEP) (الاندفاع الحاد للأدوية الحموية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدوخة والإغماء وفقدان الوعي (بسبب انخفاض ضغط الدم المصحوب بأعراض)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات البوتاسيوم في الجسم، والفشل الكلوي بعد حدوث نزيف حاد، وزيادة الضغط داخل عضلات الساقين أو الذراعين بعد حدوث نزيف، مما يؤدي إلى الألم، والتورم، وتغير الإحساس، والتنميل أو الشلل (متلازمة الحيز بعد النزيف)</p><p dir="RTL">أسأل طبيبك أو الصيدلي لمزيد من المعلومات حول الأعراض الجانبية.</p><p dir="RTL"><strong>للإبلاغ عن الأعراض الجانبية:</strong></p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:317px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ الدوائي</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فاكس 7662-205-11-966+</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهاتف الموحد: 19999</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa&nbsp;</p></td></tr></tbody></table><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى:</strong></p><p dir="RTL">الرجاء الاتصال بالمؤسسات والهيئات الوطنية لكل دولة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ هذا الدواء بعيدا عن مرأى ومتناول الأطفال.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتناول هذا الدواء بعد تاريخ انتهاء صلاحيته المطبوع على العلبة أو الشريطة. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتفظ بهذا الدواء في العلبة الأصلية لحمايته من الضوء، في مكان جاف.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة لا تزيد عن 30 درجة مئوية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء إذا لاحظت علامات تشوه العبوة أو علامات تمزق للعبوة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص يجب عدم إلقاء أي أدوية في مياه الصرف الصحي أو في النفايات المنزلية. وعليك أن تسأل الصيدلي عن كيفية التخلص من الأدوية التي لا تحتاجها. وهذه التدابير تساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li dir="RTL"><strong>المادة الفعالة</strong> هي فوروسيميد</li></ul><p dir="RTL"><em>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>أقراص <strong>درولينا</strong> 20 ملجم</em></p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحتوي كل قرص على 20 ملجم فوروسيميد.</p><p dir="RTL"><em>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>أقراص <strong>درولينا</strong> 40 ملجم</em></p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحتوي كل قرص على 40 ملجم فوروسيميد.</p><ul><li dir="RTL">المكونات<strong> الأخرى</strong> هي: لاكتوز أحادي الهيدرات، كروسكارميلوز الصوديوم، نشا، ثاني أكسيد السيليكون الغرواني، سترات المغنيسيوم، ماء نقي</li></ul>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو شكل درولينا و محتويات العبوة</strong></p><p dir="RTL"><strong>أقراص درولينا </strong><strong>20</strong><strong> ملجم</strong> هي أقراص بيضاء إلى بيضاء مائلة للصفرة، مستديرة، ذات حافة مشطوفة ذات وجه مسطح منقوش عليها JS55 على أحد الجانبين.</p><p dir="RTL"><strong>أقراص درولينا </strong><strong>40</strong><strong> ملجم</strong> هي أقراص بيضاء إلى بيضاء ، مستديرة ، مسطحة ، ذات حافة مشطوفة منقوشة JS49 على جانب واحد <strong>وخط</strong> <strong>قاسم</strong> (أي يمكن قسم القرص لقسمين) على الجانب الآخر.</p><p dir="RTL">تتوفر <strong>أقراص درولينا </strong><strong>20</strong><strong> ملجم وأقراص درولينا </strong><strong>40</strong><strong> ملجم</strong> في عبوات تحتوي على 100 قرص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ألفا فارما</p><p dir="RTL">مدينة الملك عبد الله الإقتصادية، المملكة العربية السعودية</p><p dir="RTL">هاتف: 29013 21 12 966+</p><p dir="RTL">البريد الإلكتروني: regulatory@alphapharma.com.sa</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            9/2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DROLINA 20 mg Tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DROLINA 20mg Tablets, each tablet contains 20mg of furosemide.  
Excipient with known effect 
Each tablet contains lactose (as monohydrate), see section 4.4. 
For the full list of excipients, see section 6.1. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DROLINA 20 mg tablets are white to off-white, round, flat face bevel edge tablets debossed 
JS55 on one side and plain on other side. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>DROLINA 20 mg tablets<br />&bull; &nbsp;Oedema resulting from heart or liver disease&nbsp;<br />&bull; &nbsp;Oedema due to kidney disease (treatment of the underlying disorder should be the&nbsp;<br />priority in nephrotic syndrome)&nbsp;<br />&bull; &nbsp;Arterial hypertension&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dosage should be determined on a case-by-case basis, particularly in view of the therapeutic&nbsp;<br />effect. The lowest dose providing the desired effect should always be used.&nbsp;In adults, the following dosage recommendations should be followed:&nbsp;<br />DROLINA long 30 mg prolonged-release capsules&nbsp;<br />Dosage&nbsp;<br />Oedema resulting from heart or liver disease:<br />Treatment is usually started with a single daily dose of 2 x DROLINA long 30 mg prolonged-<br />release &nbsp;capsules &nbsp;(equivalent &nbsp;to &nbsp;60 mg &nbsp;furosemide), &nbsp;taken &nbsp;in &nbsp;the morning. &nbsp;In more &nbsp;severe&nbsp;<br />cases, treatment can be initiated with 4 x DROLINA long 30 mg prolonged-release capsules&nbsp;<br />(equivalent to 120 mg furosemide) daily.&nbsp;<br />Maintenance dose: 2 x DROLINA long 30 mg prolonged-release capsules (equivalent to 60&nbsp;<br />mg furosemide) daily or every 2nd or 3rd day. If the response is inadequate, 4 x DROLINA&nbsp;<br />long 30 mg prolonged-release capsules (equivalent to 120 mg furosemide) should be given&nbsp;<br />daily or every 2nd or 3rd day.&nbsp;<br />The weight loss caused by increased diuresis should not exceed 1 kg per day.&nbsp;<br />Oedema due to kidney disease:<br />Treatment is usually started with a single daily dose of 2 x DROLINA long 30 mg prolonged-<br />release &nbsp;capsules &nbsp;(equivalent &nbsp;to &nbsp;60 mg &nbsp;furosemide), &nbsp;taken &nbsp;in &nbsp;the morning. &nbsp;In more &nbsp;severe&nbsp;<br />cases, treatment can be initiated with 4 x DROLINA long 30 mg prolonged-release capsules&nbsp;<br />(equivalent to 120 mg furosemide) daily.&nbsp;<br />Maintenance dose: 2 x DROLINA long 30 mg prolonged-release capsules (equivalent to 60&nbsp;<br />mg furosemide) daily or every 2nd or 3rd day. If the response is inadequate, 4 x DROLINA&nbsp;<br />long 30 mg prolonged-release capsules (equivalent to 120 mg furosemide) should be given&nbsp;<br />daily or every 2nd or 3rd day.&nbsp;<br />The weight loss caused by increased diuresis should not exceed 1 kg per day.&nbsp;<br />In nephrotic syndrome, the dose must be carefully adjusted because of the risk of increased&nbsp;<br />undesirable effects.&nbsp;<br />Arterial hypertension:&nbsp;<br />The usual dosage is a single dose of 2 x DROLINA long 30 mg prolonged-release capsules&nbsp;<br />(equivalent to 60 mg furosemide) daily, alone or in combination with other medicinal products.&nbsp;<br />In more severe cases, 4 x DROLINA long 30 mg prolonged-release capsules (equivalent to&nbsp;<br />120 mg furosemide) daily can be administered initially.&nbsp;DROLINA 40 mg tablets&nbsp;<br />Dosage&nbsp;<br />Oedema resulting from heart or liver disease:<br />The &nbsp;initial &nbsp;dose &nbsp;in &nbsp;adults &nbsp;is &nbsp;usually &nbsp;1 &nbsp;x &nbsp;DROLINA &nbsp;40 &nbsp;mg &nbsp;tablet &nbsp;(equivalent &nbsp;to &nbsp;40 &nbsp;mg&nbsp;<br />furosemide). If adequate diuresis is not achieved, the single dose can be doubled after 6 hours&nbsp;<br />to 2 x DROLINA 40 mg tablets (equivalent to 80 mg furosemide). If satisfactory diuresis is still&nbsp;<br />not &nbsp;attained, &nbsp;4 &nbsp;x &nbsp;DROLINA &nbsp;40 &nbsp;mg &nbsp;tablets &nbsp;(equivalent &nbsp;to &nbsp;160 &nbsp;mg &nbsp;furosemide) &nbsp;can &nbsp;be&nbsp;<br />administered after a further 6 hours. If necessary, initial doses over 200 mg furosemide can&nbsp;<br />be used in exceptional cases under careful clinical supervision.&nbsp;<br />The daily maintenance dose is usually 1 - 2 DROLINA 40 mg tablets (equivalent to 40 - 80 mg&nbsp;<br />furosemide).&nbsp;<br />The weight loss caused by increased diuresis should not exceed 1 kg per day.&nbsp;<br />Oedema due to kidney disease:<br />The &nbsp;initial &nbsp;dose &nbsp;in &nbsp;adults &nbsp;is &nbsp;usually &nbsp;1 &nbsp;x &nbsp;DROLINA &nbsp;40 &nbsp;mg &nbsp;tablet &nbsp;(equivalent &nbsp;to &nbsp;40 &nbsp;mg&nbsp;<br />furosemide). If adequate diuresis is not achieved, the single dose can be doubled after 6 hours&nbsp;<br />to 2 x DROLINA 40 mg tablets (equivalent to 80 mg furosemide). If satisfactory diuresis is still&nbsp;<br />not &nbsp;attained, &nbsp;4 &nbsp;x &nbsp;DROLINA &nbsp;40 &nbsp;mg &nbsp;tablets &nbsp;(equivalent &nbsp;to &nbsp;160 &nbsp;mg &nbsp;furosemide) &nbsp;can &nbsp;be&nbsp;<br />administered after a further 6 hours. If necessary, initial doses over 200 mg furosemide can&nbsp;<br />be used in exceptional cases under careful clinical supervision.&nbsp;<br />The daily maintenance dose is usually 1 - 2 DROLINA 40 mg tablets (equivalent to 40 - 80 mg&nbsp;<br />furosemide).&nbsp;<br />The weight loss caused by increased diuresis should not exceed 1 kg per day.&nbsp;<br />In nephrotic syndrome, the dose must be carefully adjusted because of the risk of increased&nbsp;<br />undesirable effects.&nbsp;<br />Oedema due to burns:<br />The daily and/or single dose is between 1 and 2 &frac12; DROLINA 40 mg tablets (equivalent to 40&nbsp;<br />- 100 mg furosemide). In exceptional cases with impaired renal function, up to 6 x DROLINA&nbsp;<br />40 mg tablets (equivalent to 240 mg furosemide) can be administered.&nbsp;<br />Intravascular volume depletion must be corrected before using DROLINA 40 mg tablets.&nbsp;<br />Arterial hypertension:&nbsp;<br />The usual dose is 1 x DROLINA 40 mg tablet (equivalent to 40 mg furosemide) once daily,&nbsp;<br />alone or in combination with other medicinal products.&nbsp;Use in children:<br />Children generally receive 1 (to 2) mg furosemide per kg body weight/day, with a maximum of&nbsp;<br />40 mg furosemide per day.&nbsp;<br />&nbsp;<br />DROLINA 500 mg Tabs&nbsp;<br />Dosage&nbsp;<br />Oliguria in advanced and terminal renal failure (predialysis and dialysis stages):<br />To &nbsp;increase diuresis, daily doses of up &nbsp;to 1,000 mg &nbsp;furosemide can be administered while&nbsp;<br />monitoring hydration and serum electrolyte levels. It should be checked whether furosemide&nbsp;<br />is continuing to increase diuresis by occasionally discontinuing treatment.&nbsp;<br />In patients with chronic renal failure, the dose must be carefully adjusted so that mobilisation&nbsp;<br />of oedema fluid is achieved gradually.&nbsp;<br />The switch to DROLINA 500 mg Tabs should only be made if there is an inadequate response&nbsp;<br />to an oral dose of 120 mg &nbsp;furosemide per day. The dose of &frac12; &nbsp;x DROLINA 500 mg Tabs&nbsp;<br />(equivalent &nbsp;to 250 mg &nbsp;furosemide) can be &nbsp;increased &nbsp;to up &nbsp;to 2 x DROLINA 500 mg Tabs&nbsp;<br />(equivalent to 1,000 mg furosemide).&nbsp;<br />DROLINA long 30 mg prolonged-release capsules / DROLINA 40 mg tablets / DROLINA 500&nbsp;<br />mg Tabs&nbsp;<br />Method of administration and duration of use<br />The &nbsp;tablets &nbsp;/ &nbsp;prolonged-release &nbsp;capsules &nbsp;should &nbsp;be &nbsp;taken &nbsp;on &nbsp;an &nbsp;empty &nbsp;stomach &nbsp;and&nbsp;<br />swallowed whole with adequate liquid (e.g. 1 glass of water).&nbsp;<br />The duration of use depends on the nature and severity of the disorder.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DROLINA  long  30  mg  prolonged-release  capsules  /  DROLINA  40  mg  tablets 
DROLINA long 30 mg prolonged-release capsules or DROLINA 40 mg tablets must 
not be used in the following cases:  
−  hypersensitivity  to  furosemide,  sulfonamides  (possible  cross  sensitivity  with 
furosemide) or to any of the excipients listed in section 6.1, 
−  renal failure with anuria refractory to furosemide therapy,  
−  hepatic coma and precoma associated with hepatic encephalopathy,  
−  severe hypokalaemia (see section 4.8),  
−  severe hyponatraemia,  
−  hypovolaemia or dehydration,  
−  breastfeeding mothers.  
DROLINA 500 mg Tabs DROLINA 500 mg Tabs must not be used in the following 
cases:  
−  normal renal function or impaired renal function with glomerular filtration values 
greater  than  20  ml/min  because  there  is  a  risk  of  excessive  water  and 
electrolyte loss in these cases,  
−  hypersensitivity  to  furosemide,  sulfonamides  (possible  cross  sensitivity  with 
furosemide) or to any of the excipients listed in section 6.1,  
−  renal failure with anuria refractory to furosemide therapy,  
−  hepatic coma and precoma associated with hepatic encephalopathy,  
−  severe hypokalaemia (see section 4.8),  
−  severe hyponatraemia,  
−  hypovolaemia or dehydration,  
−  breastfeeding mothers. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>the following situations:<br />&minus; &nbsp;hypotension,<br />&minus; &nbsp;manifest or latent diabetes mellitus (regular monitoring of blood sugar levels),<br />&minus; &nbsp;gout (regular monitoring of serum uric acid),<br />&minus; &nbsp;impaired micturition (e.g. in prostatic hypertrophy, hydronephrosis, ureteral stenosis),<br />&minus; &nbsp;hypoproteinaemia, e.g. in nephrotic syndrome (careful adjustment of the dose),<br />&minus; &nbsp;hepatorenal syndrome (rapidly progressing renal insufficiency combined with severe<br />liver disease, e.g. liver cirrhosis),<br />&minus; &nbsp;patients who would be at particular risk from an unwanted significant drop in blood<br />pressure, e.g. patients with cerebrovascular circulatory disorders or coronary heart<br />disease,<br />&minus; &nbsp;premature infants (risk of developing nephrocalcinosis/nephrolithiasis; monitoring of<br />renal function, kidney ultrasound).<br />In premature infants with respiratory distress syndrome, diuretic treatment with furosemide in<br />the first weeks of life can increase the risk of persistence of patent ductus arteriosus.<br />Symptomatic hypotension leading to dizziness, fainting or loss of consciousness can occur in<br />patients treated with furosemide, particularly in the elderly, patients on other medications<br />which can cause hypotension and patients with other medical conditions that are risks for<br />hypotension.<br />In patients with micturition disorders (e.g. prostatic hypertrophy) furosemide should only be<br />used if provision has been made for free flow of urine since sudden urine production can lead<br />to urinary retention with overextension of the bladder.&nbsp;Furosemide leads to increased elimination of sodium and chloride and therefore water.<br />Elimination of other electrolytes (particularly potassium, calcium and magnesium) is also<br />increased. Since fluid-electrolyte balance disorders are often observed during treatment with<br />DROLINA due to increased electrolyte elimination, serum electrolytes should be monitored<br />regularly.<br />Particularly during long-term therapy with DROLINA, serum electrolytes (especially<br />potassium, sodium, calcium), bicarbonate, creatinine, urea and uric acid as well as blood<br />sugar levels should be monitored regularly.<br />Particularly close monitoring is required in patients with a high risk of developing electrolyte<br />disorders, or in the case of severe fluid depletion (e.g. due to vomiting, diarrhoea or intense<br />sweating). Hypovolaemia or dehydration and pronounced electrolyte disturbances or<br />disruption of the acid-base balance must be corrected. This may require temporary<br />discontinuation of treatment with furosemide.<br />Possible development of electrolyte disorders is affected by underlying disease (e.g. liver<br />cirrhosis, heart failure), concomitant medication (see Section 4.5) and diet.<br />The weight loss caused by increased urine excretion should not exceed 1 kg/day irrespective<br />of the extent of urine excretion.<br />In nephrotic syndrome, the dose must be carefully adjusted because of the risk of increased<br />undesirable effects.<br />Concomitant use with risperidone:<br />In placebo-controlled studies with risperidone in elderly patients with dementia, a higher<br />incidence of mortality was observed in patients treated with furosemide plus risperidone (7.3%;<br />mean age 89 years, range 75-97 years) when compared to patients treated with risperidone<br />alone (3.1%; mean age 84 years, range 70-96 years) or furosemide alone (4.1%; mean age<br />80 years, range 67-90 years). Concomitant use of risperidone with other diuretics (mainly lowdose<br />thiazide diuretics) was not associated with similar findings.<br />No pathophysiological mechanism has been identified to explain this finding, and no consistent<br />pattern for cause of death observed. Nevertheless, caution should be exercised and the risks<br />and benefits of this combination or co-treatment with other potent diuretics should be<br />considered before the decision to treat is made. There was no increased incidence of mortality<br />among patients taking other diuretics as concomitant treatment with risperidone. Irrespective<br />of treatment, dehydration was an overall risk factor for mortality and should therefore be<br />avoided in elderly patients with dementia (see Section 4.3).<br />The possibility exists of exacerbation or activation of systemic lupus erythematosus.<br />Use of DROLINA can yield positive results in doping tests. In addition, the abuse of DROLINA<br />as a doping agent can endanger health.</p><p>Warnings on specific excipients<br />Patients with the rare hereditary disorders galactose intolerance, lactase<br />deficiency or glucose-galactose malabsorption should not take DROLINA 40 mg tablets and<br />DROLINA 500 mg Tabs.<br />Patients with the rare hereditary disorders fructose intolerance, glucose-galactose<br />malabsorption or sucrose-isomaltase deficiency, should not take DROLINA long 30 mg<br />prolonged-release capsules.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The simultaneous use of furosemide and glucocorticoids, carbenoxolone or laxatives can lead<br />to increased potassium depletion with the risk of hypokalaemia. In this respect, large amounts<br />of licorice act like carbenoxolone.<br />Non-steroidal anti-inflammatory drugs (e.g. indometacin and acetylsalicylic acid) can reduce<br />the effect of furosemide. In patients who develop hypovolaemia during furosemide therapy, or<br />in those who are dehydrated, the simultaneous administration of non-steroidal antiinflammatory<br />agents can trigger acute renal failure.<br />Probenecid, methotrexate and other medicinal products which, like furosemide, are<br />extensively secreted in the renal tubules, can reduce the effect of furosemide.<br />On concomitant administration with phenytoin, a reduced effect of furosemide has been<br />described.<br />As sucralfate reduces the uptake of furosemide from the intestine and therefore reduces its<br />effect, an interval of at least 2 hours should be allowed between administration of the two<br />medicinal products.<br />On concomitant administration with cardiac glycosides, furosemide-related hypokalaemia<br />and/or hypomagnesaemia increase the sensitivity of the myocardium to cardiac glycosides.<br />There is a greater risk of ventricular arrhythmias (including torsades de pointes) if furosemide<br />is used concomitantly with medicinal products that can cause a prolonged QT interval (e.g.<br />terfenadine, some class I and class III antiarrhythmic agents), and in patients with electrolyte<br />disturbances.<br />The toxicity of high-dose salicylates can be potentiated when they are administered<br />concomitantly with furosemide.<br />Furosemide can potentiate the harmful effects of nephrotoxic medicinal products (e.g.<br />antibiotics such as aminoglycosides, cephalosporins, polymyxins).<br />Deterioration in renal function may be observed in patients who are treated concomitantly with<br />furosemide and high doses of certain cephalosporins.<br />The ototoxicity of aminoglycosides (e.g. kanamycin, gentamicin, tobramycin) and other<br />ototoxic medicinal products<br />can be increased by the simultaneous administration of furosemide. Any hearing disorders<br />that occur may be irreversible. The simultaneous use of the above mentioned medicinal<br />products should therefore be avoided.<br />If cisplatin and furosemide are administered concomitantly, hearing damage may occur. If<br />forced diuresis with furosemide is attempted during cisplatin treatment, furosemide should<br />only be used at low doses (e.g. 40 mg in patients with normal renal function) and when there&nbsp;is a positive fluid balance. Otherwise, cisplatin nephrotoxicity may be enhanced.<br />The concomitant administration of furosemide and lithium leads to an increase in the cardiac<br />and neurotoxic effects of lithium via reduced lithium excretion. It is therefore recommended<br />that plasma lithium levels be carefully monitored in patients receiving this combination.<br />If other antihypertensive agents, diuretics or medicinal products with blood-pressure-lowering<br />potential are used at the same time as furosemide, a greater drop in blood pressure is to be<br />expected. A severe drop in blood pressure or even shock, and a deterioration in renal function<br />(in isolated cases acute renal failure), have been observed, particularly when an ACE inhibitor<br />or angiotensin-II-receptor antagonist were administered for the first time or for the first time in<br />higher doses. If possible, the furosemide therapy should therefore be temporarily<br />discontinued, or the dose at least reduced for three days before treatment with an ACE<br />inhibitor or angiotensin-II-receptor antagonist is started or doses are increased.<br />Furosemide can reduce the renal elimination of probenecid, methotrexate and other medicinal<br />products which, like furosemide, are extensively secreted in renal tubules. In high-dose<br />treatment (especially with both furosemide and the other medicinal product), this can lead to<br />elevated serum levels and a greater risk of undesirable effects due to furosemide or the<br />concomitant medication.<br />The effect of theophylline or curare-type muscle relaxants may be increased by furosemide.<br />The effect of antidiabetic agents or hypertensive sympathomimetics (e.g. epinephrine,<br />norepinephrine) may be reduced if furosemide is coadministered.<br />In patients treated with risperidone, caution should be exercised and the risks and benefits of<br />the combination or co-treatment with furosemide, or with other potent diuretics, should be<br />considered before a decision to treat is made. (See Section 4.4 regarding increased mortality<br />in elderly patients with dementia receiving risperidone concomitantly.)<br />Levothyroxine: High doses of furosemide may inhibit binding of thyroid hormones to carrier<br />proteins<br />and thereby lead to an initial transient increase in free thyroid hormones, followed by an overall<br />decrease in total thyroid hormone levels. Thyroid hormone levels should be monitored.<br />Other interactions<br />The concomitant administration of cyclosporin A and furosemide is associated with an<br />increased risk of gouty arthritis as a result of furosemide-induced hyperuricaemia and<br />impairment of renal uric acid excretion by cyclosporin.<br />In patients who were at high risk of renal damage due to X-ray contrast media and who were<br />treated with furosemide, a deterioration in renal function occurred more frequently after a<br />contrast examination than in at-risk patients who received only an intravenous supply of fluid<br />(hydration) before the contrast-enhanced examination.<br />After intravenous administration of furosemide within 24 hours of treatment with chloral<br />hydrate, a feeling of heat, outbreaks of sweating, restlessness, nausea, a rise in blood<br />pressure, and tachycardia may be experienced in isolated cases. The simultaneous use of<br />furosemide and chloral hydrate should therefore be avoided.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy&nbsp;<br />Furosemide should only be used in pregnancy for short periods and after the need to treat is&nbsp;<br />carefully &nbsp;weighed &nbsp;as &nbsp;it &nbsp;crosses &nbsp;the &nbsp;placental &nbsp;barrier.&nbsp;<br />Diuretics are not suitable for the routine treatment of hypertension and oedema in pregnancy,&nbsp;&nbsp;since &nbsp;they &nbsp;impair &nbsp;placental &nbsp;perfusion &nbsp;and &nbsp;thereby &nbsp;intrauterine &nbsp;growth.&nbsp;<br />However, &nbsp;if &nbsp;furosemide &nbsp;has &nbsp;to &nbsp;be &nbsp;given &nbsp;in &nbsp;maternal &nbsp;heart &nbsp;failure &nbsp;or &nbsp;renal &nbsp;insufficiency,&nbsp;<br />electrolytes &nbsp;and &nbsp;haematocrit &nbsp;as &nbsp;well &nbsp;as &nbsp;the &nbsp;foetal &nbsp;growth &nbsp;must &nbsp;be &nbsp;closely &nbsp;monitored.&nbsp;<br />Displacement &nbsp;of &nbsp;bilirubin &nbsp;from &nbsp;the &nbsp;albumin &nbsp;binding &nbsp;site, &nbsp;resulting &nbsp;in &nbsp;an &nbsp;increased &nbsp;risk &nbsp;of&nbsp;<br />kernicterus &nbsp;in &nbsp;hyperbilirubinaemia, &nbsp;has &nbsp;been &nbsp;described &nbsp;for &nbsp;furosemide.&nbsp;<br />Furosemide crosses the placental barrier and reaches 100% of maternal serum concentration&nbsp;<br />in &nbsp;cord &nbsp;blood. &nbsp;No &nbsp;malformations &nbsp;in &nbsp;humans &nbsp;that &nbsp;could &nbsp;be &nbsp;associated &nbsp;with &nbsp;exposure &nbsp;to&nbsp;<br />furosemide &nbsp;have &nbsp;been &nbsp;reported &nbsp;to &nbsp;date. &nbsp;There &nbsp;is &nbsp;however &nbsp;insufficient &nbsp;data &nbsp;to &nbsp;provide &nbsp;a&nbsp;<br />conclusive assessment of possible damaging effects on &nbsp;the embryo/foetus. &nbsp;In utero &nbsp;foetal&nbsp;<br />urine &nbsp;production may &nbsp;be &nbsp;stimulated. &nbsp;Urolithiasis &nbsp;has &nbsp;been &nbsp;observed &nbsp;in &nbsp;premature &nbsp;infants&nbsp;<br />treated &nbsp;with &nbsp;furosemide.&nbsp;<br />Breastfeeding&nbsp;<br />Furosemide is excreted in breast milk and inhibits lactation. Women should therefore not be&nbsp;<br />treated &nbsp;with &nbsp;furosemide &nbsp;if &nbsp;they &nbsp;are &nbsp;breastfeeding. &nbsp;If &nbsp;necessary, &nbsp;breastfeeding &nbsp;should &nbsp;be&nbsp;<br />discontinued (also see Section 4.3).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As individual reactions may vary, the ability to drive, use machines or work without a secure&nbsp;<br />support may be impaired. This applies particularly at the start of treatment, when doses are&nbsp;<br />increased or treatments are switched, or when the drug is taken with alcohol.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following categories are used to assess the incidence rates of undesirable effects:&nbsp;<br />Very common (&ge; 1/10)&nbsp;<br />Common (&ge; 1/100 to &lt; 1/10)&nbsp;<br />Uncommon (&ge; 1/1,000 to &lt; 1/100)&nbsp;<br />Rare (&ge; 1/10,000 to &lt; 1/1,000)&nbsp;<br />Very rare (&lt; 1/10,000)&nbsp;<br />Not known (frequency cannot be estimated from the available data)&nbsp;<br />The incidence rates of adverse effects are based on literature data and refer to studies that&nbsp;<br />included a total of 1,387 patients receiving various doses of furosemide in a number of different&nbsp;<br />indications.&nbsp;<br />Blood and lymphatic system disorders:<br />Common: haemoconcentration (through excessive diuresis).&nbsp;<br />Uncommon: thrombocytopenia.&nbsp;<br />Rare: eosinophilia, leukocytopenia.&nbsp;<br />Very rare: haemolytic anaemia, aplastic anaemia, agranulocytosis.&nbsp;<br />Signs of agranulocytosis may include fever with shivering, mucous membrane changes and&nbsp;<br />sore throat.&nbsp;</p><p>Immune system disorders:<br />Uncommon: &nbsp;allergic &nbsp;skin &nbsp;and mucous membrane &nbsp;reactions &nbsp;(see &nbsp;&quot;Skin and &nbsp;subcutaneous&nbsp;<br />tissue disorders&rdquo;).&nbsp;<br />Rare: &nbsp;severe &nbsp;anaphylactic &nbsp;and &nbsp;anaphylactoid &nbsp;reactions &nbsp;such &nbsp;as &nbsp;anaphylactic &nbsp;shock &nbsp;(for&nbsp;<br />treatment, see Section 4.9).&nbsp;<br />The &nbsp;first &nbsp;signs &nbsp;of &nbsp;shock &nbsp;include &nbsp;skin &nbsp;reactions &nbsp;such &nbsp;as &nbsp;flushing &nbsp;or &nbsp;urticaria, &nbsp;restlessness,&nbsp;<br />headache, sweating, nausea, cyanosis.&nbsp;<br />Not known: exacerbation or activation of systemic lupus erythematosus.&nbsp;<br />Metabolism and nutrition disorders (see Section 4.4):<br />Very common: Electrolyte disorders (including symptomatic manifestations), dehydration and&nbsp;<br />hypovolaemia (particularly in elderly patients), elevated triglycerides.&nbsp;<br />Common: &nbsp;hyponatraemia &nbsp;and &nbsp;hypochloraemia &nbsp;(particularly &nbsp;in &nbsp;restricted &nbsp;sodium &nbsp;chloride&nbsp;<br />intake), &nbsp;hypokalaemia &nbsp;(particularly &nbsp;in &nbsp;concomitant &nbsp;reduction &nbsp;of &nbsp;potassium &nbsp;intake &nbsp;and/or&nbsp;<br />increased &nbsp;potassium &nbsp;losses, &nbsp;e.g. &nbsp;due &nbsp;to &nbsp;vomiting &nbsp;or &nbsp;chronic &nbsp;diarrhoea); &nbsp;elevated &nbsp;blood&nbsp;<br />cholesterol, elevated blood uric acid and episodes of gout.&nbsp;<br />Uncommon: &nbsp;reduced &nbsp;glucose &nbsp;tolerance &nbsp;and &nbsp;hyperglycaemia. &nbsp;In &nbsp;patients &nbsp;with &nbsp;manifest&nbsp;<br />diabetes mellitus, this canlead to deterioration of the metabolic state. Latent diabetes mellitus&nbsp;<br />may become manifest (see Section 4.4).&nbsp;<br />Not known: &nbsp;hypocalcaemia, &nbsp;hypomagnesaemia, &nbsp;metabolic &nbsp;alkalosis, &nbsp;Pseudo-Bartter&nbsp;<br />syndrome in the context of misuse and/or long-term use of furosemide.&nbsp;<br />Commonly &nbsp;observed &nbsp;symptoms &nbsp;of &nbsp;sodium &nbsp;deficiency &nbsp;include &nbsp;apathy, &nbsp;calf &nbsp;cramps, &nbsp;loss &nbsp;of&nbsp;<br />appetite, weakness, drowsiness, vomiting and confusion.&nbsp;<br />Hypokalaemia &nbsp;may &nbsp;manifest &nbsp;as &nbsp;neuromuscular &nbsp;signs &nbsp;(muscle &nbsp;weakness, &nbsp;paraesthesia,&nbsp;<br />paraesis), &nbsp;intestinal &nbsp;signs &nbsp;(vomiting, &nbsp;constipation, &nbsp;meteorism), &nbsp;renal &nbsp;signs &nbsp;(polyuria,&nbsp;<br />polydipsia) &nbsp;and &nbsp;cardiac &nbsp;signs &nbsp;(disorders &nbsp;of &nbsp;impulse &nbsp;formation &nbsp;and &nbsp;conduction). &nbsp;Severe&nbsp;<br />potassium depletion can result in paralytic ileus, consciousness disorders or even coma.&nbsp;<br />Hypocalcaemia can cause tetany in rare cases.&nbsp;<br />Tetany or &nbsp;the development of cardiac arrhythmias have been observed &nbsp;in &nbsp;rare cases as a&nbsp;<br />result of hypomagnesaemia.&nbsp;<br />Nervous system disorders:<br />Common: hepatic encephalopathy in patients with hepatic insufficiency (see Section 4.3).&nbsp;<br />Rare: paraesthesia.&nbsp;<br />Not known: Dizziness, fainting and loss of consciousness, headache.&nbsp;<br />Ear and labyrinth disorders:<br />Uncommon: &nbsp;hearing &nbsp;disorders, &nbsp;mostly &nbsp;reversible, &nbsp;particularly &nbsp;in &nbsp;patients &nbsp;with &nbsp;renal&nbsp;<br />insufficiency or hypoproteinaemia &nbsp;(e.g. &nbsp;in nephrotic syndrome) and/or on excessively &nbsp;rapid&nbsp;<br />intravenous injection. Deafness (sometimes irreversible).&nbsp;<br />Rare: tinnitus.&nbsp;&nbsp;Vascular disorders:&nbsp;<br />Very common (on intravenous infusion): hypotension including orthostatic dysregulation (see&nbsp;<br />Section 4.4).&nbsp;<br />Rare: vasculitis.&nbsp;<br />Not known: thrombosis (particularly in elderly patients).&nbsp;<br />In excessive diuresis, circulatory disorders (even circulatory collapse) may occur, especially&nbsp;<br />in &nbsp;children &nbsp;and &nbsp;elderly &nbsp;patients, &nbsp;and &nbsp;mainly &nbsp;manifest &nbsp;as &nbsp;headaches, &nbsp;dizziness, &nbsp;visual&nbsp;<br />disorders, dry mouth and thirst, hypotension and orthostatic dysregulation.&nbsp;<br />Gastrointestinal disorders:<br />Uncommon: nausea.&nbsp;<br />Rare: vomiting, diarrhoea.&nbsp;<br />Very rare: acute pancreatitis.&nbsp;<br />Hepatobiliary disorders:<br />Very rare: intrahepatic cholestasis, elevated transaminases.&nbsp;<br />Skin and subcutaneous tissue disorders:<br />Uncommon: pruritus, urticaria, rash, bullous dermatitis, erythema&nbsp;<br />&nbsp;<br />multiforme, pemphigoid, exfoliative dermatitis, purpura, photosensitivity.&nbsp;<br />Not known: &nbsp;Stevens-Johnson &nbsp;syndrome, &nbsp;toxic &nbsp;epidermal &nbsp;necrolysis, &nbsp;acute &nbsp;generalised&nbsp;<br />exanthaemotic &nbsp;pustulosis &nbsp;(AGEP), &nbsp;Drug &nbsp;Rash &nbsp;with &nbsp;Eosinophilia &nbsp;and &nbsp;Systemic &nbsp;Symptoms&nbsp;<br />(DRESS).&nbsp;<br />Musculoskeletal and connective tissue disorders:<br />Not known: &nbsp;cases &nbsp;of &nbsp;rhabdomyolysis &nbsp;have &nbsp;been &nbsp;reported, &nbsp;often &nbsp;in &nbsp;the &nbsp;context &nbsp;of &nbsp;severe&nbsp;<br />hypokalaemia (see section 4.3)&nbsp;<br />Renal and urinary disorders:<br />Very common: elevated blood creatinine.&nbsp;<br />Common: increased urine volume.&nbsp;<br />Rare: tubulointerstitial nephritis.&nbsp;<br />Not known: elevated urine sodium, elevated urine chloride, elevated blood urea, symptoms&nbsp;<br />of &nbsp;impaired micturition &nbsp;(e.g. &nbsp;in patients with prostatic hypertrophy, hydronephrosis, ureteral&nbsp;<br />stenosis) &nbsp;to &nbsp;urinary &nbsp;retention &nbsp;with &nbsp;secondary &nbsp;complications &nbsp;(see &nbsp;Section &nbsp;4.4),&nbsp;<br />nephrocalcinosis and/or nephrolithiasis &nbsp;in premature &nbsp;infants &nbsp;(see Section 4.4), &nbsp;renal &nbsp;failure&nbsp;<br />(see Section 4.5).&nbsp;<br />Congenital, familial and genetic disorders:<br />Not known: increased risk of persistence of patent ductus arteriosus if premature infants are&nbsp;<br />treated with furosemide in the first weeks of life.&nbsp;</p><p>General disorders:<br />Rare: fever.&nbsp;<br />To report any side effect(s):<br /> &nbsp;Saudi Arabia:<br />&minus; &nbsp;The National Pharmacovigilance Centre (NPC)&nbsp;<br />Fax: +966-11-205-7662&nbsp;<br />SFDA Call Center: 19999&nbsp;<br />E-mail: npc.drug@sfda.gov.sa &nbsp;<br />Website: https://ade.sfda.gov.sa &nbsp;<br /> &nbsp;Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>a) Symptoms of overdose<br />The clinical picture in acute or chronic overdose depends on the extent of water and&nbsp;<br />electrolyte loss. Overdose can lead to hypotension, orthostatic dysregulation, electrolyte&nbsp;<br />disturbances (hypokalaemia, hyponatraemia, hypochloraemia) or alkalosis. In more severe&nbsp;<br />fluid depletion, pronounced hypovolaemia, dehydration, circulatory collapse and&nbsp;<br />haemoconcentration with a tendency to thrombosis may occur. In rapid water and electrolyte&nbsp;<br />losses, delirium may be observed. In rare cases, anaphylactic shock (symptoms:&nbsp;<br />sweating, nausea, cyanosis, significant drop in blood pressure, consciousness disorders or&nbsp;<br />even coma) may be observed.&nbsp;<br />b) Treatment of overdose<br />In cases of overdose or in patients with signs of hypovolaemia (hypotension, orthostatic&nbsp;<br />dysregulation), treatment with DROLINA must be discontinued immediately.&nbsp;<br />If only a short time has passed since furosemide was taken orally, it is advisable to take&nbsp;<br />steps for the primary elimination of poisoning (induced vomiting, gastric lavage) and&nbsp;<br />absorption-reducing measures (activated charcoal).&nbsp;<br />In more severe cases, vital signs must be monitored along with repeated assessments of the&nbsp;<br />water and electrolyte balance, acid-base balance, blood sugar levels and substances&nbsp;<br />excreted in urine, and any abnormal levels corrected if necessary.&nbsp;<br />In patients with impaired micturition (e.g. prostatic hypertrophy) provision must be made for&nbsp;<br />free flow of urine because sudden urine production can lead to urinary retention with&nbsp;<br />overextension of the bladder.&nbsp;<br />Treatment of hypovolaemia: volume replacement.&nbsp;</p><p>Treatment of hypokalaemia: potassium replacement.&nbsp;<br />Treatment of circulatory collapse: patients should be placed in the shock position, if&nbsp;<br />necessary shock therapy.&nbsp;<br />Emergency measures in the event of anaphylactic shock:&nbsp;<br />At the first signs (e.g. skin reactions such as urticaria or flushing, restlessness, headache,&nbsp;<br />outbreaks of sweating, nausea, cyanosis):&nbsp;<br />- &nbsp;place venous access,&nbsp;<br />- &nbsp;along with usual emergency measures, place the patient in a supine position with the&nbsp;<br />legs raised, keep the airways clear and give oxygen,&nbsp;<br />- &nbsp;if &nbsp;necessary, &nbsp;implement &nbsp;other &nbsp;intensive &nbsp;care &nbsp;emergency &nbsp;measures &nbsp;(including &nbsp;the&nbsp;<br />administration of epinephrine, volume replacement fluids, glucocorticoids).&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: high-ceiling diuretic&nbsp;<br />ATC code: C03CA01&nbsp;<br />Furosemide is a potent, short- and fast-acting loop diuretic. By blocking the Na+/2Cl-/K+ ion&nbsp;<br />carrier, it inhibits reabsorption of these ions in the ascending limb of the loop of Henle.&nbsp;<br />Fractional sodium excretion can constitute up to 35% of the sodium that has undergone&nbsp;<br />glomerular filtration. Increased sodium excretion leads to greater urine excretion and an&nbsp;<br />increase in K+ secretion in the distal tubules via&nbsp;<br />osmotically bound water. Excretion of Ca2+ and Mg2+ ions is also increased. In addition to&nbsp;<br />the depletion of these electrolytes, reduced excretion of uric acid and disruption of the acid-<br />base balance leading to possible metabolic alkalosis may occur.&nbsp;<br />Furosemide interrupts the tubuloglomerular feedback mechanism in the macula densa so&nbsp;<br />that saluretic efficacy is not attenuated.&nbsp;<br />Furosemide leads to dose-dependent stimulation of the renin-angiotensin-aldosterone&nbsp;<br />system.&nbsp;<br />In heart failure, furosemide causes an acute reduction in the preload on the heart by dilating&nbsp;<br />the venous capacitance vessels. This early vascular effect appears to be mediated by&nbsp;<br />prostaglandins and requires adequate renal function with activation of the renin-angiotensin-<br />aldosterone system and intact prostaglandin synthesis.&nbsp;<br />Furosemide lowers blood pressure as a result of increased sodium chloride excretion and a&nbsp;<br />reduced response of the smooth vascular musculature to vasoconstrictor stimuli, and through&nbsp;<br />decreased blood volume.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Approximately 65% of the dose is absorbed after oral administration. The plasma half-life is&nbsp;<br />biphasic with a terminal elimination phase of about 1&frac12; hours. Furosemide is up to 99% bound&nbsp;<br />to plasma proteins and is mainly excreted in the urine, largely unchanged, but also excreted&nbsp;<br />in &nbsp;the bile, non-renal elimination being considerably &nbsp;increased &nbsp;in &nbsp;renal &nbsp;failure. Furosemide&nbsp;<br />crosses the placental barrier and is excreted in the milk.&nbsp;<br />Furosemide &nbsp;is &nbsp;a &nbsp;weak &nbsp;carboxylic &nbsp;acid &nbsp;which &nbsp;exists mainly &nbsp;in &nbsp;the &nbsp;dissociated &nbsp;form &nbsp;in &nbsp;the&nbsp;<br />gastrointestinal &nbsp;tract. &nbsp;Furosemide &nbsp;is &nbsp;rapidly &nbsp;but &nbsp;incompletely &nbsp;absorbed &nbsp;(60-70%) &nbsp;on &nbsp;oral&nbsp;<br />administration and its effect is largely over within 4 hours. The optimal absorption site is the&nbsp;<br />upper duodenum at pH 5.0. Regardless of route of administration 69-97% of activity from a&nbsp;<br />radio-labelled dose is excreted in the first 4 hours after the drug is given. Furosemide is bound&nbsp;<br />to plasma albumin and little biotransformation takes place. Furosemide is mainly eliminated&nbsp;<br />via the kidneys (80-90%); a small fraction of the dose undergoes biliary elimination and 10-<br />15% of the activity can be recovered from the faeces.&nbsp;<br />In renal/ hepatic impairment&nbsp;<br />Where liver disease is present, biliary elimination is reduced up to 50%. Renal impairment has&nbsp;<br />little effect on &nbsp;the elimination &nbsp;rate of &nbsp;furosemide, but &nbsp;less &nbsp;than 20% &nbsp;residual &nbsp;renal &nbsp;function&nbsp;<br />increases the elimination time.&nbsp;<br />The elderly&nbsp;<br />The &nbsp;elimination &nbsp;of &nbsp;furosemide &nbsp;is &nbsp;delayed &nbsp;in &nbsp;the &nbsp;elderly &nbsp;where &nbsp;a &nbsp;certain &nbsp;degree &nbsp;of &nbsp;renal&nbsp;<br />impairment is present.&nbsp;<br />New born&nbsp;<br />A sustained diuretic effect is seen in the newborn, possibly due to immature tubular function.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute oral toxicity was found to be low in all the studied species. Chronic toxicity studies in&nbsp;<br />rats and dogs gave rise to changes in the kidneys (including fibrosis and calcification).&nbsp;<br />In vitro and in vivo genotoxicity studies with furosemide provided no clinically relevant&nbsp;<br />evidence of genotoxic potential.&nbsp;<br />Long-term studies in rats and mice showed no evidence of carcinogenic potential.&nbsp;<br />Following &nbsp;the &nbsp;administration &nbsp;of &nbsp;high &nbsp;doses &nbsp;in &nbsp;reproductive &nbsp;toxicology &nbsp;studies, &nbsp;a &nbsp;reduced&nbsp;<br />number of differentiated glomeruli and skeletal anomalies &nbsp;in &nbsp;the scapula, humerus and ribs&nbsp;<br />(due to hypokalaemia) were observed in rat foetuses, as well as hydronephrosis in mouse and&nbsp;<br />rabbit foetuses.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose monohydrate supertab 11SD&nbsp;<br />Croscarmellose sodium primellose&nbsp;<br />Partially pregelatinized maize starch (starch 1500)&nbsp;<br />Colloidal silicone dioxide aerosil 200 pharma&nbsp;<br />Magnesium stearate&nbsp;<br />Purified water&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable. &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years (24 Months).  
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30 &ordm;C and keep in the original pack to protect from light, in a dry place.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>DROLINA 20 mg tablets are white to off-white, round, flat face bevel edge tablets debossed JS55&nbsp;<br />on one side and plain on other side.&nbsp;</p><p>DROLINA 20 mg tablets and DROLINA 40 mg tablets are available in pack containing 100 tablets.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of &nbsp;in accordance with&nbsp;<br />local requirements, Keep out of the reach &amp; sight of children&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Alpha Pharma,  
Kingdom of Saudi Arabia, Rabigh 
Tel: +966 12 21 29013 
For  any  information  about  this  medicinal  product,  please  contact  the  Regulatory  affairs 
department of authorization holder:  
Regulatory affairs department  
Riyadh, Saudi Arabia  
Tel: +966112931722 Ex:102 - 104 
Email: regulatory@alphapharma.com.sa 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                13/9/2022 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>